Hypofractionated Radiation Therapy for Localized Prostate Cancer: An ASTRO, ASCO, and AUA Evidence-Based Guideline
2018 · Journal of Clinical Oncology · 175 citations
https://doi.org/10.1200/jco.18.01097
K
Karen E. Hoffman
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
216
Papers
5.8K
Citations
40
h-index
102
i10-index
Karen E. Hoffman is an academic researcher from The University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Prostate Cancer Diagnosis and Treatment & Prostate Cancer Treatment and Research & Advanced Radiotherapy Techniques. The author has an h-index of 40, co-authored 184 publications.
Papers by this author
worksFunctional Outcomes After Localized Prostate Cancer Treatment
2024 · JAMA · 83 citations
https://doi.org/10.1001/jama.2023.26491
Definition and Validation of “Favorable High-Risk Prostate Cancer”: Implications for Personalizing Treatment of Radiation-Managed Patients
2015 · International Journal of Radiation Oncology*Biology*Physics · 42 citations
https://doi.org/10.1016/j.ijrobp.2015.07.2281
Long-term economic value of hypofractionated prostate radiation: Secondary analysis of a randomized trial
2017 · Advances in Radiation Oncology · 22 citations
https://doi.org/10.1016/j.adro.2017.07.010
Regional differences in recommended cancer treatment for the elderly
2016 · BMC Health Services Research · 10 citations
https://doi.org/10.1186/s12913-016-1534-z
Proton therapy toxicity outcomes for localized prostate cancer: Long-term results at a comprehensive cancer center
2024 · Clinical and Translational Radiation Oncology · 6 citations
https://doi.org/10.1016/j.ctro.2024.100822
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat